Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice

BACKGROUND: Histone deacetylase (HDAC) inhibitors, developed as promising anti-tumor drugs, exhibit their anti-inflammatory properties due to their effects on reduction of inflammatory cytokines. OBJECTIVE: To investigate the protective effect of butyrate, a HDAC inhibitor, on lipopolysaccharide (LP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Yun-Feng, Wang, Jian, Yan, Xiao-Long, Tian, Feng, Zhao, Jin-Bo, Wang, Yun-Jie, Jiang, Tao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848144/
https://www.ncbi.nlm.nih.gov/pubmed/20302656
http://dx.doi.org/10.1186/1465-9921-11-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848144/
https://www.ncbi.nlm.nih.gov/pubmed/20302656
http://dx.doi.org/10.1186/1465-9921-11-33

Ejemplares similares